CU06-1004
methyl (E)-6-[(3S,8S,9S,10R,13S,14S,17R)-3-[[(2R,3S)-3-acetyloxy-2-(acetyloxymethyl)-3,6-dihydro-2H-pyran-6-yl]oxy]-10,13-dimethyl-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-17-yl]hept-5-enoate
Molecular Identity
CU06-1004
methyl (E)-6-[(3S,8S,9S,10R,13S,14S,17R)-3-[[(2R,3S)-3-acetyloxy-2-(acetyloxymethyl)-3,6-dihydro-2H-pyran-6-yl]oxy]-10,13-dimethyl-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-17-yl]hept-5-enoate
PubChem CID: 154695939
2D Structure
Properties
C37H54O8
Molecular Formula
626.80
Molecular Weight
g/mol
626.3819
Exact Mass
Da
7
XLogP
Above Lipinski threshold
97.4
TPSA
Good oral absorption (< 140 A²)
0
H-Bond Donors
8
H-Bond Acceptors
1200
Complexity
SMILES
Canonical SMILES
SMILES: Synonyms(8)
CU06-10041296734-08-1orb1942107SCHEMBL23516856DA-52157PD207310HY-155946CS-0890046
Data from PubChem (NCBI)
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Drug Network
Trials and conditions connected to CU06-1004
Loading drug network...